Glenmark gets USFDA nod for Ursodial; stk up

MUMBAI: Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals, has been granted final approval for Ursodial tablets by the USFDA. The drug is used for treatment of patients with primary biliary cirrhosis.

Glenmark Pharmaceuticals was at Rs 321.15, up 2.36 per cent on the BSE. It touched a high of Rs 321.90 and low of Rs 314.20 in trade so far.